9 June 2015 - Deborah Wilkes
Archived
The US Food and Drug Administration (FDA) has given the okay to two of Johnson & Johnson's OTC manufacturing plants that are operating under a consent decree. The company is still waiting for news on a third OTC manufacturing plant covered by the decree.
New to OTCToolbox?
This is available as part of an Annual Subscription to the OTCToolbox website.